Stellantis, an automotive manufacturer, is recalling around 1.5 million Ram pickup trucks due to a software issue that can disable a vehicle's electronic stability control (ESC). In a statement ...

Stellantis is recalling nearly 1.5 million Ram pickup trucks worldwide over a software problem that can disable the electronic stability control system. According to Stellantis, the trucks may ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

(RTTNews) - Stellantis is recalling about 1.5 million Ram pickup trucks worldwide to address a software issue that may disable the electronic stability control system, according to several media ...

DETROIT — Stellantis is recalling nearly 1.5 million Ram pickup trucks worldwide to fix a software problem that can disable the electronic stability control system. The recall covers certain ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

DETROIT — Stellantis is recalling nearly 1.5 million Ram pickup trucks worldwide to fix a software problem that can disable the electronic stability control system. The recall covers certain ...

29 (20) 17 (18) 12 (24) HHT-specific quality-of-life score‖ 6.3±3.1 5.8±2.9 7.1±3.4 Median daily epistaxis duration (IQR) — min/day** 11.7 (5.8–20.6) 11.1 (4.0–19.1) 12.4 (7.1–26.6 ...

Car manufacturer Stellantis has announced an urgent recall for nearly 1.5 million Ram pickup trucks worldwide. The recall is due to a software problem that could disable the electronic stability ...

The half-ton truck gets its name not from its weight but from its payload capacity. These versatile vehicles are the middle ground between heavy-duty trucks and small pickups, offering better fuel ...

A reduction of more than 5 points on the modified Lee Symptom Scale was reported in 60%, 69%, and 41% of the patients in the three dose groups, respectively. The most common adverse events were ...